These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 15553674

  • 21. [The effect of tumor-dendritic cell fusion vaccines on the cytotoxicity of CIK/NK cells from cord blood].
    Li Y, Huang SL, Wu YF, Wei J, Meng Y, Zhou DH, Bao R.
    Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):269-72. PubMed ID: 15949286
    [Abstract] [Full Text] [Related]

  • 22. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M, Tanaka Y, Yagi J, Uchiyama T, Ogawa K.
    Anticancer Res; 2008 May; 28(5B):2921-31. PubMed ID: 19031935
    [Abstract] [Full Text] [Related]

  • 23. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.
    Chen W, Chan AS, Dawson AJ, Liang X, Blazar BR, Miller JS.
    Biol Blood Marrow Transplant; 2005 Jan; 11(1):23-34. PubMed ID: 15625541
    [Abstract] [Full Text] [Related]

  • 24. Natural killer cells license dendritic cell cross-presentation of B lymphoma cell--associated antigens.
    Dao T, Gomez-Nunez M, Antczak C, Kappel B, Jaggi JS, Korontsvit T, Zakhaleva V, Scheinberg DA.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8763-72. PubMed ID: 16361564
    [Abstract] [Full Text] [Related]

  • 25. Transfer of in vitro expanded T lymphocytes after activation with dendritomas prolonged survival of mice challenged with EL4 tumor cells.
    Li J, Theofanous L, Stickel S, Bouton-Verville H, Burgin KE, Jakubchak S, Wagner TE, Wei Y.
    Int J Oncol; 2007 Jul 15; 31(1):193-7. PubMed ID: 17549421
    [Abstract] [Full Text] [Related]

  • 26. Functions of natural killer cells.
    Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S.
    Nat Immunol; 2008 May 15; 9(5):503-10. PubMed ID: 18425107
    [Abstract] [Full Text] [Related]

  • 27. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
    Fujii S.
    Trends Immunol; 2008 May 15; 29(5):242-9. PubMed ID: 18372215
    [Abstract] [Full Text] [Related]

  • 28. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
    Hammer MH, Brestrich G, Mittenzweig A, Roemhild A, Zwinger S, Subklewe M, Beier C, Kurtz A, Babel N, Volk HD, Reinke P.
    J Immunother; 2007 May 15; 30(8):817-24. PubMed ID: 18049333
    [Abstract] [Full Text] [Related]

  • 29. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
    Kontani K, Teramoto K, Ozaki Y, Sawai S, Tezuka N, Ishida H, Kajino K, Fujino S, Yamauchi A, Taguchi O, Kannagi R, Yokomise H, Ogasawara K.
    Oncol Rep; 2007 Apr 15; 17(4):895-902. PubMed ID: 17342333
    [Abstract] [Full Text] [Related]

  • 30. Bacillus Calmette-Guérin-pulsed dendritic cells stimulate natural killer T cells and gammadeltaT cells.
    Naoe M, Ogawa Y, Takeshita K, Morita J, Iwamoto S, Miyazaki A, Yoshida H.
    Int J Urol; 2007 Jun 15; 14(6):532-8; discussion 538. PubMed ID: 17593099
    [Abstract] [Full Text] [Related]

  • 31. Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
    Yang SC, Batra RK, Hillinger S, Reckamp KL, Strieter RM, Dubinett SM, Sharma S.
    Cancer Res; 2006 Mar 15; 66(6):3205-13. PubMed ID: 16540672
    [Abstract] [Full Text] [Related]

  • 32. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
    Shi YX, Zhang XS, Xia JC, Li YQ, Xu RH, Han WJ, Zhang JH, Guan ZZ, Jiang WQ.
    Ai Zheng; 2007 Aug 15; 26(8):837-42. PubMed ID: 17697543
    [Abstract] [Full Text] [Related]

  • 33. Mouse CD146/MCAM is a marker of natural killer cell maturation.
    Despoix N, Walzer T, Jouve N, Blot-Chabaud M, Bardin N, Paul P, Lyonnet L, Vivier E, Dignat-George F, Vély F.
    Eur J Immunol; 2008 Oct 15; 38(10):2855-64. PubMed ID: 18958886
    [Abstract] [Full Text] [Related]

  • 34. Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells.
    Bontkes HJ, Kramer D, Ruizendaal JJ, Meijer CJ, Hooijberg E.
    Clin Immunol; 2008 Jun 15; 127(3):375-84. PubMed ID: 18358784
    [Abstract] [Full Text] [Related]

  • 35. Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma.
    O-Sullivan I, Kim TS, Chopra A, Cohen EP.
    Anticancer Res; 2006 Jun 15; 26(2A):873-84. PubMed ID: 16619482
    [Abstract] [Full Text] [Related]

  • 36. NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.
    Morandi B, Mortara L, Carrega P, Cantoni C, Costa G, Accolla RS, Mingari MC, Ferrini S, Moretta L, Ferlazzo G.
    Int Immunol; 2009 May 15; 21(5):599-606. PubMed ID: 19325034
    [Abstract] [Full Text] [Related]

  • 37. Generation of anti-tumour effector T cells from naïve T cells by stimulation with dendritic/tumour fusion cells.
    Ishida A, Tanaka H, Hiura T, Miura S, Watanabe S, Matsuyama K, Kuriyama H, Tanaka J, Kagamu H, Gejyo F, Yoshizawa H.
    Scand J Immunol; 2007 Nov 15; 66(5):546-54. PubMed ID: 17953530
    [Abstract] [Full Text] [Related]

  • 38. Helper role of NK cells during the induction of anticancer responses by dendritic cells.
    Kalinski P, Giermasz A, Nakamura Y, Basse P, Storkus WJ, Kirkwood JM, Mailliard RB.
    Mol Immunol; 2005 Feb 15; 42(4):535-9. PubMed ID: 15607810
    [Abstract] [Full Text] [Related]

  • 39. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells.
    Bohnenkamp HR, Burchell JM, Taylor-Papadimitriou J, Noll T.
    J Immunol Methods; 2004 Nov 15; 294(1-2):67-80. PubMed ID: 15604017
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
    Hoskin DW, Mader JS, Furlong SJ, Conrad DM, Blay J.
    Int J Oncol; 2008 Mar 15; 32(3):527-35. PubMed ID: 18292929
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.